Primary record
3-(6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo(6.4.1.0^(4,13))trideca-2,4,6,8(13)-tetraen-3-yl)-4-(imidazo(1,2-a)pyridin-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione
- 库存
- 8,947 克
- 纯度
- 98.1 %
- CAS
- 603288-22-8
化合物标识与属性
- CAS
- 603288-22-8
- PubChem CID
- 10029385
- SMILES
- C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7
- Canonical SMILES
- O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2
名称与同义词
- LY2090314
- 603288-22-8
- Kinome_3681
- LY-2090314
- UNII-822M3GYM67
- RefChem:154536
- LY 2090314
- D0Z1DH
- CHEMBL362558
- 822M3GYM67
- SCHEMBL633455
- CHEBI:167661
- DTXSID90209085
- MFCD20526532
- GTPL7958
- orb1307529
- SCHEMBL29533963
- C28H25FN6O3
- DTXCID10131576
- HRJWTAWVFDCTGO-UHFFFAOYSA-N
- GLXC-06318
- GSK-3 Inhibitor LY2090314
- HMS3673E17
- HMS3747E07
- BCP07855
- EX-A2214
- ZINC3817327
- BDBM50150699
- NSC772198
- NSC801005
- s7063
- AKOS026750195
- AKOS032950045
- CCG-269790
- CS-1633
- DB11913
- NSC-772198
- NSC-801005
- SB16558
- 3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
- CID10029385
- LY 2090314 [WHO-DD]
- NCGC00378942-02
- NCGC00378942-05
- AC-32724
- AK547885
- AS-56097
- BC600682
- CID 10029385
- DA-55098
- FL104294
- HY-16294
- QC-11735
- A3570
- FT-0698670
- LY2090314?
- NS00069302
- J2.867.237C
- A12741
- LY2090314, >=98% (HPLC)
- A868999
- BRD-K78055238-001-01-8
- Q27082598
- 3-[6-Fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione
- 3-[9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-1H-pyrrole-2,5-dione
- 110-218-9
- 1H-PYRROLE-2,5-DIONE, 3-(9-FLUORO-1,2,3,4-TETRAHYDRO-2-(1-PIPERIDINYLCARBONYL)PYRROLO(3,2,1-JK)(1,4)BENZODIAZEPIN-7-YL)-4-IMIDAZO(1,2-A)PYRIDIN-3-YL-
- 2-(Imidazo[1,2-a]pyridine-3-yl)-3-[2-(piperidinocarbonyl)-9-fluoro-1,2,3,4-tetrahydropyrrolo[3,2,1-jk][1,4]benzodiazepine-7-yl]maleimide
- 3-(6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo(6.4.1.0^(4,13))trideca-2,4,6,8(13)-tetraen-3-yl)-4-(imidazo(1,2-a)pyridin-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione
- 3-(9-Fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione
- 3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-(imidazo(1,2-a)pyridin-3-yl)-1H-pyrrole-2,5-dione
- 3-(9-fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(H-imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
- 3-(Imidazo[1,2-a]pyridin-3-yl)-4-(2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-1H-pyrrole-2,5-dione
- 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.0?,(1)(3)]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-1H-pyrrole-2,5-dione
- 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-{imidazo[1,2-a]pyridin-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione
- 3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-yl-pyrrole-2,5-dione
- 3-[9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
- 3-[9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-pyrrole-2,5-dione
- 3-[9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione
- 3-Imidazo[1,2-a]pyridin-3-yl-4-[1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-1H-pyrrole-2,5-dione
- 603281-60-3
- PYRROLO(3,2,1-JK)(1,4)BENZODIAZEPINE, 7-(2,5-DIHYDRO-4-IMIDAZO(1,2-A)PYRIDIN-3-YL-2,5-DIOXO-1H-PYRROL-3-YL)-9-FLUORO-1,2,3,4-TETRAHYDRO-2-(1-PIPERIDINYLCARBONYL)-